Clinical Trial Update: Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing the hypoglycemic response of NN1250 to insulin glargine in adults with Type 1 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED